Beovu Action Proceeds Against Novartis in Ark. Federal Court



DOCUMENTS
  • Order


LITTLE ROCK, Ark. — An Arkansas federal judge has allowed a Beovu action to proceed against Novartis Pharmaceuticals Corp., ruling the plaintiff pointed to possible “newly discovered evidence” that would have supported a label change via the Changes Being Effected process.

In a Sept. 19 order, Judge Kristine G. Baker of the U.S. District Court for the Eastern District of Arkansas noted the plaintiff proffered new clinical studies and adverse event reports that were submitted before she received her injection of the drug.

Barbara Frye was injected with Beovu on Jan. 28, 2020, to treat neovascular (wet) age-related macular degeneration …

FIRM NAMES
  • Hollingsworth LLP
  • Johnson Becker PLLC
  • Keith Law Group
  • PPGMR Law PLLC





UPCOMING CONFERENCES




HarrisMartin’s Webinar Series: Acetaminophen ASD/ADHD Product Liability Litigation

October 21, 2022

MORE DETAILS



HarrisMartin's Webinar Series: The Hottest Upcoming Device Projects - Strattice Hernia Mesh & Exactech Hip Implants

November 09, 2022

MORE DETAILS